Avivagen Stock Today
| VIVXF Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 86
|
Avivagen is trading at 1.0E-4 as of the 28th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Avivagen has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Avivagen are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of September 2024 and ending today, the 28th of November 2024. Click here to learn more.
Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada. The company has 77.19 M outstanding shares. More on Avivagen
Moving against Avivagen Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Avivagen Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Avivagen [VIVXF] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Avivagen's market, we take the total number of its shares issued and multiply it by Avivagen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Avivagen classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 77.19 M outstanding shares.
Avivagen has accumulated about 494.81 K in cash with (4.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Avivagen Probability Of Bankruptcy
Ownership AllocationAvivagen holds a total of 77.19 Million outstanding shares. Almost 98.57 percent of Avivagen outstanding shares are held by general public with 1.43 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Avivagen Ownership Details
Avivagen Risk Profiles
| Mean Deviation | 2.9 | |||
| Standard Deviation | 11.97 | |||
| Variance | 143.21 | |||
| Risk Adjusted Performance | (0.08) |
Avivagen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Avivagen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Avivagen Corporate Management
| Tracy BVSC | Director Mang | Profile | |
| Drew Basek | Director Relations | Profile | |
| James Nickerson | Pres Innovation | Profile | |
| Graham Burton | Chief CoFounder | Profile | |
| Ira Levy | Interim Officer | Profile | |
| G Anthony | CEO Director | Profile |
Other Information on Investing in Avivagen Pink Sheet
Avivagen financial ratios help investors to determine whether Avivagen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avivagen with respect to the benefits of owning Avivagen security.